心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 临床实践指南：应用体外循环(ECLS/ECMO) 治疗心脏和循环衰竭

2021-11-22 国外急诊/重症相关专家小组（统称） ESC Heart Fail

心力衰竭循环衰竭

体外循环（体外生命支持[ECLS]或静脉动脉体外膜肺氧合[va-ECMO]）在心脏和循环衰竭的机械支持中广泛应用。

中文标题：

2021 临床实践指南：应用体外循环(ECLS/ECMO) 治疗心脏和循环衰竭

英文标题：

Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3

发布机构：

国外急诊/重症相关专家小组（统称）

发布日期：

2021-11-22

简要介绍：

体外循环（体外生命支持[ECLS]或静脉动脉体外膜肺氧合[va-ECMO]）在心脏和循环衰竭的机械支持中广泛应用。本文主要针对应用体外循环(ECLS／ECMO) 治疗心脏和循环衰竭的相关内容提供循证指导建议，内容涉及ECLS启动、持续、撤机和后续管理等。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 临床实践指南：应用体外循环(ECLS／ECMO)+治疗心脏和循环衰竭.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5b6c51c0022e120a, title=2021 临床实践指南：应用体外循环(ECLS/ECMO) 治疗心脏和循环衰竭, enTitle=Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3, guiderFrom=ESC Heart Fail, authorId=0, author=, summary=体外循环（体外生命支持[ECLS]或静脉动脉体外膜肺氧合[va-ECMO]）在心脏和循环衰竭的机械支持中广泛应用。, cover=https://img.medsci.cn/20211214/1639463852251_1614372.png, journalId=0, articlesId=null, associationId=2150, associationName=国外急诊/重症相关专家小组（统称）, associationIntro=国外急诊/重症相关专家小组（统称）, copyright=0, guiderPublishedTime=Mon Nov 22 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">体外循环（体外生命支持[ECLS]或静脉动脉体外膜肺氧合[va-ECMO]）在心脏和循环衰竭的机械支持中广泛应用。本文主要针对应用体外循环(ECLS／ECMO) 治疗心脏和循环衰竭的相关内容提供循证指导建议，内容涉及ECLS启动、持续、撤机和后续管理等。</span></p>, tagList=[TagDto(tagId=335, tagName=心力衰竭), TagDto(tagId=36276, tagName=循环衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=36276, guiderKeyword=循环衰竭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4955, appHits=191, showAppHits=0, pcHits=1394, showPcHits=4764, likes=0, shares=11, comments=10, approvalStatus=1, publishedTime=Thu Nov 25 17:38:18 CST 2021, publishedTimeString=2021-11-22, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Thu Nov 25 17:21:47 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 10:46:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 临床实践指南：应用体外循环(ECLS／ECMO)+治疗心脏和循环衰竭.pdf)])
2021 临床实践指南：应用体外循环(ECLS／ECMO)+治疗心脏和循环衰竭.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2139714, encodeId=f4342139e14d0, content=真棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9bc8568570, createdName=ms2000001202936872, createdTime=Mon May 29 16:13:41 CST 2023, time=2023-05-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1210562, encodeId=c3e2121056225, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd82771281, createdName=344084472, createdTime=Tue Apr 12 14:49:08 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197098, encodeId=2b22119e0988d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Fri Feb 25 08:13:57 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181644, encodeId=612c1181644e3, content=很不错，有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Thu Jan 06 23:45:40 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078569, encodeId=76bd10e856930, content=ECPR.间很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce901342316, createdName=gaosfhg, createdTime=Thu Dec 09 20:55:15 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2023-05-29 ms2000001202936872 来自上海

    真棒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2139714, encodeId=f4342139e14d0, content=真棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9bc8568570, createdName=ms2000001202936872, createdTime=Mon May 29 16:13:41 CST 2023, time=2023-05-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1210562, encodeId=c3e2121056225, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd82771281, createdName=344084472, createdTime=Tue Apr 12 14:49:08 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197098, encodeId=2b22119e0988d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Fri Feb 25 08:13:57 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181644, encodeId=612c1181644e3, content=很不错，有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Thu Jan 06 23:45:40 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078569, encodeId=76bd10e856930, content=ECPR.间很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce901342316, createdName=gaosfhg, createdTime=Thu Dec 09 20:55:15 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2022-04-12 344084472

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2139714, encodeId=f4342139e14d0, content=真棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9bc8568570, createdName=ms2000001202936872, createdTime=Mon May 29 16:13:41 CST 2023, time=2023-05-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1210562, encodeId=c3e2121056225, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd82771281, createdName=344084472, createdTime=Tue Apr 12 14:49:08 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197098, encodeId=2b22119e0988d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Fri Feb 25 08:13:57 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181644, encodeId=612c1181644e3, content=很不错，有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Thu Jan 06 23:45:40 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078569, encodeId=76bd10e856930, content=ECPR.间很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce901342316, createdName=gaosfhg, createdTime=Thu Dec 09 20:55:15 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2022-02-25 ms8000000018254969

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2139714, encodeId=f4342139e14d0, content=真棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9bc8568570, createdName=ms2000001202936872, createdTime=Mon May 29 16:13:41 CST 2023, time=2023-05-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1210562, encodeId=c3e2121056225, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd82771281, createdName=344084472, createdTime=Tue Apr 12 14:49:08 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197098, encodeId=2b22119e0988d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Fri Feb 25 08:13:57 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181644, encodeId=612c1181644e3, content=很不错，有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Thu Jan 06 23:45:40 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078569, encodeId=76bd10e856930, content=ECPR.间很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce901342316, createdName=gaosfhg, createdTime=Thu Dec 09 20:55:15 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2022-01-06 karlxun

    很不错，有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2139714, encodeId=f4342139e14d0, content=真棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9bc8568570, createdName=ms2000001202936872, createdTime=Mon May 29 16:13:41 CST 2023, time=2023-05-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1210562, encodeId=c3e2121056225, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd82771281, createdName=344084472, createdTime=Tue Apr 12 14:49:08 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197098, encodeId=2b22119e0988d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Fri Feb 25 08:13:57 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181644, encodeId=612c1181644e3, content=很不错，有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Thu Jan 06 23:45:40 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078569, encodeId=76bd10e856930, content=ECPR.间很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce901342316, createdName=gaosfhg, createdTime=Thu Dec 09 20:55:15 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2021-12-09 gaosfhg

    ECPR.间很大

    0

相关指南

2021更新 NICE指南：急性心力衰竭的诊断和管理

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2021-11-17

沙库巴曲缬沙坦钠共晶物药学特性专家共识

中国药学会医院药学专业委员会 · 2021-08-12

将姑息疗法整合到心力衰竭护理中：欧洲心脏病学会心力衰竭协会立场文件

欧洲心脏病学会(ESC,European Society of Cardiology) · 2021-11-02

欧洲心脏病学会/心力衰竭协会关于新型降糖药物在心力衰竭患者中的作用和安全性的立场文件

欧洲心脏病学会(ESC,European Society of Cardiology) · 2021-11-04

心力衰竭中的SGLT2抑制剂：超出血糖控制： 欧洲心脏病学会心力衰竭协会立场文件

欧洲心脏病学会(ESC,European Society of Cardiology) · 2021-11-02

心力衰竭患者的 COVID-19疫苗接种：欧洲心脏病学会心力衰竭协会的立场文件

欧洲心脏病学会(ESC,European Society of Cardiology) · 2021-10-01